Pfizer Unit Can't Force Actavis To Alter Generic Drug Label
By Caroline Simson ( January 21, 2015, 7:46 PM EST) -- A British patent court ruled Wednesday that Pfizer unit Warner-Lambert Co. LLC cannot force Actavis UK Ltd. to place a notice on the packaging of its upcoming generic version of Lyrica warning pharmacists not to use the drug to fill prescriptions for neuropathic pain, as Warner-Lambert's patent already precludes that indication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.